Karbon Capital Partners 3Q 2026: Net income $3.06M — 10-Q Summary

Karbon Capital Partners reported a net income of $3.06M for 3Q 2026, reversing a net loss from the prior-year period. The income was driven by $3.2M in interest from Trust Account securities, offsetting $184,565 in expenses. The company has no operating revenue yet and focuses on business combinations in energy sectors. Trust Account securities totaled $355.0M, with $321,384 in cash and $41,056 in working capital as of September 30, 2026. Management noted potential liquidity concerns.

Original reporting
Published Nov 13, 2026, 11:11 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 11:20 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Karbon Capital Partners 3Q 2026: Net income $3.06M — 10-Q Summary — source image
Decision brief

The 30-second read

$KBONNeutralLow
01

Why it matters

The filing provides the first earnings data for the SPAC, confirming a profit but highlighting limited cash and a going‑concern warning.

02

Market read

Micro‑cap earnings release with modest profit; limited trading relevance beyond the ticker.

03

What to watch

Potential need for additional financing could outweigh the positive earnings surprise.

Relevance 5/10Novelty 6/10Timing: post‑market filing release

Background

Karbon Capital Partners is a SPAC seeking a business combination in power generation and energy infrastructure. The 10‑Q shows a small profit driven by interest income on trust assets.

Company-level read

Ticker impact

$KBONNeutralMedium confidence
Context

Karbon Capital Partners reported Q3 net income of $3.06M, a turnaround from a prior loss, in its 10‑Q filing.

Expected impact

likely modest pressure as investors weigh the profit against limited cash and need for additional financing

Evidence & confidence

Profit is small and cash is low; market may view the result as a positive sign but remain cautious about liquidity.

Market effects

Limited impact on the broader energy infrastructure sector; the filing is company‑specific.

Minimal, as the company is a micro‑cap with limited trading volume.

None

Counterpoint

The profit may be a one‑off from trust account earnings and not indicative of sustainable operations.

Key entities

  • Karbon Capital Partners Corp.

    SPAC targeting energy sector acquisitions.

Related articles

$SBCHigh

Why SBC Medical Stock Skyrocketed on Friday

SBC Medical Group (NASDAQ:SBC) shares rose 37% after reporting Q3 revenue of $59M, up 35% YoY, and announcing an AI partnership with NeuroBrain Dynamics. The company added 36 clinics, increasing total locations to 293, and saw a 9% rise in patient visits. Operating income surged 66% to $26M, with a 45% operating margin.

$BTOMedAI 8/10

B2Gold Earnings Call Signals Lower Costs and Growth

B2Gold Corp. reported Q3 earnings with strong production, lower cost guidance, and positive free cash flow. The company produced 193,000 ounces of gold, reduced all-in sustaining cost guidance by over $100 per ounce, and generated $48 million in free cash flow. Revenue reached $836 million, supported by higher gold prices. The company also highlighted growth projects and shareholder returns.

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.